Formulations for the oral administration of therapeutic agents and related methods

Details for Australian Patent Application No. 2008255525 (hide)

Owner The University of British Columbia

Inventors Wasan, Kishor M.; Wasan, Ellen K.

Agent Davies Collison Cave

Pub. Number AU-A-2008255525

PCT Pub. Number WO2008/144888

Priority 60/976,708 01.10.07 US; 60/940,307 25.05.07 US; 61/041,478 01.04.08 US

Filing date 23 May 2008

Wipo publication date 4 December 2008

International Classifications

A61K 47/24 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - containing atoms other than carbon, hydrogen, halogen, oxygen, nitrogen or sulfur

A61K 9/107 (2006.01) Medicinal preparations characterised by special physical form - Emulsions

A61K 31/7048 (2006.01)

A61K 45/06 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

A61K 45/08 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

A61K 47/14 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Esters of carboxylic acids

A61P 31/10 (2006.01) Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

A61P 33/02 (2006.01) Antiparasitic agents

Event Publications

21 January 2010 PCT application entered the National Phase

  PCT publication WO2008/144888 Priority application(s): WO2008/144888

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008255526-Humanized and chimeric anti-CD59 antibodies that mediate cancer cell cytotoxicity

2008255518-Process for preparing the stable, amorphous calcium salt of (6S)-N(5)-methyl-5,6,7,8-tetrahydrofolic acid